Analysts expect CalciMedica, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - |
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analysts expect CalciMedica, Inc. to report earnings per share of -1.30 for Q3 26, against a range of -1.40 to -1.20. The most recent reported quarter, Q2 26, came in at -2.25, a 50.0% miss against the -1.50 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -2.50 | -1.85 | -1.80 | -2.00 | -2.60 | -3.40 | 1.50 | -2.25 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -2.45 | -1.93 | -1.38 | -1.55 | -1.94 | -2.00 | -1.29 | -1.44 | -1.20 | -0.98 | 1.26 | -2.05 | -1.94 | -1.84 | 1.87 | -1.28 | ||||||||||
| Low Estimate | -2.91 | -2.05 | -1.58 | -1.77 | -2.30 | -2.22 | -1.57 | -1.56 | -1.40 | -1.04 | 1.06 | -2.49 | -2.08 | -2.00 | 1.53 | -1.50 | ||||||||||
| Consensus Estimate | -2.68 | -1.99 | -1.48 | -1.66 | -2.12 | -2.11 | -1.43 | -1.50 | -1.30 | -1.01 | 1.16 | -2.27 | -2.01 | -1.92 | 1.70 | -1.39 |